Zobrazeno 1 - 10
of 17 231
pro vyhledávání: ''
Autor:
Thi-Van-Trinh Tran, Carole Rubino, Rodrigue Allodji, Milena Andruccioli, Stéphane Bardet, Ibrahima Diallo, Massimo Dottorini, Jérome Garsi, Per Hall, Michel Henry-Amar, Stephanie Lamart, Françoise Le Thai, Stefan Lönn, Marcel Ricard, Claire Schvartz, Martin Schlumberger, Neige Journy, Florent de Vathaire
Publikováno v:
British Journal of Cancer. 127:2118-2124
Female thyroid cancer survivors are more likely to have a higher risk of breast cancer compared to the general population, and the underlying causes are yet to be understood. The potential role of I-131 treatment on this association remains controver
Publikováno v:
Breast Cancer Research and Treatment. 196:441-451
Neoadjuvant systemic therapy (NAST) can be an effective treatment option for patients with HER2 + or triple negative breast cancer (TNBC). However, its use in geriatric patients is largely understudied. Our aim is to investigate the effect of NAST in
Publikováno v:
Breast Cancer Research and Treatment. 196:67-74
Purpose Elderly patients have different physical condition and tumor biology of breast cancer. Surgical choices for older patients are complicated and several studies have reported that breast conserving surgery (BCS) had better survival than mastect
Autor:
Adriana Garduño-Alanis, Lizbeth Morales-González, Angélica Ángeles-Llerenas, José Zaim Delgado-Ramírez, Carolina Ortega-Olvera, Gabriela Torres-Mejía
Publikováno v:
Cancer Causes & Control. 33:1355-1361
The delay in the time (in calendar days) from the delivery of mammography results to histopathological breast cancer (BC) diagnosis could be associated with more advanced clinical stages, a worse prognosis and higher mortality. Therefore, we assessed
Autor:
Hasmeena Kathuria, Adrian Gunawan, Matthew Spring, Sara Aijaz, Vinson Cobb, Carmel Fitzgerald, Cornelia Wakeman, Jinesa Howard, Mary Clancy, Alexis Gallardo Foreman, Ve Truong, Carolina Wong, Katrina Steiling, Karen E. Lasser, Katia Bulekova, Renda Soylemez Wiener
Publikováno v:
Cancer Causes & Control. 33:1373-1380
Medicare requires tobacco dependence counseling and shared decision-making (SDM) for lung cancer screening (LCS) reimbursement. We hypothesized that initiating SDM during inpatient tobacco treatment visits would increase LCS among patients with barri
Publikováno v:
Cancer Causes & Control. 33:1161-1172
Purpose To quantitatively evaluate contributions of trends in incidence, relative survival, and stage at diagnosis to the dynamics in the prevalence of major cancers (lung, prostate, colon, breast, urinary bladder, ovaries, stomach, pancreas, esophag
Autor:
Yudai Hojo, Tatsuro Nakamura, Tsutomu Kumamoto, Yasunori Kurahashi, Yoshinori Ishida, Yoshitaka Kitayama, Toshihiko Tomita, Hisashi Shinohara
Publikováno v:
Gastric Cancer. 25:1117-1122
Duodenogastroesophageal reflux (DGER) following esophagectomy or gastrectomy can cause severe esophagitis, which impairs patients' quality of life and increases the risk of esophageal carcinogenesis. It is sometimes resistant to medical treatment, an
Publikováno v:
Breast Cancer Research and Treatment. 194:507-516
To compare the outcome of allogeneic stem cell transplantation for myeloid malignancies in breast cancer survivors to a contemporaneous control group.Medical records of all patients with a history of breast cancer who received allogeneic stem cell tr
Autor:
Assaf, Berger, Kenneth, Bernstein, Juan Diego, Alzate, Reed, Mullen, Joshua S, Silverman, Erik P, Sulman, Bernadine R, Donahue, Anna C, Pavlick, Jason, Gurewitz, Monica, Mureb, Janice, Mehnert, Kathleen, Madden, Amy, Palermo, Jeffrey S, Weber, John G, Golfinos, Douglas, Kondziolka
Publikováno v:
Journal of Neuro-Oncology. 158:471-480
New therapies for melanoma have been associated with increasing survival expectations, as opposed to the dismal outcomes of only a decade ago. Using a prospective registry, we aimed to define current survival goals for melanoma patients with brain me
Autor:
Laura E. Fischer, Sebastian Stintzing, Ludwig Fischer von Weikersthal, Dominik P. Modest, Thomas Decker, Alexander Kiani, Florian Kaiser, Salah-Eddin Al-Batran, Tobias Heintges, Christian Lerchenmüller, Christoph Kahl, Gernot Seipelt, Frank Kullmann, Martina Stauch, Werner Scheithauer, Clemens Giessen-Jung, Jens Uhlig, Bettina Peuser, Claudio Denzlinger, Arndt Stahler, Lena Weiss, Kathrin Heinrich, Swantje Held, Andreas Jung, Thomas Kirchner, Volker Heinemann
Publikováno v:
British Journal of Cancer. 127:836-843
Summary Background The evidence on the efficacy of anticancer therapy is limited in older patients with metastatic colorectal cancer (mCRC). This retrospective analysis of phase III FIRE-3 trial assesses the efficacy of FOLFIRI plus either cetuximab